 0 Table of Contents |
  1 Home Page |
  2 Genomic Background |
  3 General Genomic Reporting |
  4 Artifact List |
   4.1 Find Population Diagnostic Implications |
   4.2 Find Population Molecular Consequences |
   4.3 Find Population Specific Haplotypes |
   4.4 Find Population Specific Variants |
   4.5 Find Population Structural Intersecting Variants |
   4.6 Find Population Structural Subsuming Variants |
   4.7 Find Population Treatment Implications |
   4.8 Find Study Metadata |
   4.9 Find Subject Diagnostic Implications |
   4.10 Find Subject Haplotypes |
   4.11 Find Subject Molecular Consequences |
   4.12 Find Subject Specific Haplotypes |
   4.13 Find Subject Specific Variants |
   4.14 Find Subject Structural Intersecting Variants |
   4.15 Find Subject Structural Subsuming Variants |
   4.16 Find Subject Treatment Implications |
   4.17 Find Subject Variants |
   4.18 Genomic Base |
   4.19 Genomic Finding |
   4.20 Genomic Implication |
   4.21 Diagnostic Implication |
   4.22 Followup Recommendation |
   4.23 Genomic Annotation |
   4.24 Genomic Data File |
   4.25 Genomic Report |
   4.26 Genomic Study Metadata |
   4.27 Genotype |
   4.28 Haplotype |
   4.29 Medication Recommendation |
   4.30 Molecular Biomarker |
   4.31 Molecular Consequence |
   4.32 Sequence Phase Relationship |
   4.33 Therapeutic Implication |
   4.34 Variant |
   4.35 Coded Annotation |
   4.36 Annotation Code |
   4.37 Genomic Report Note |
   4.38 Genomic Risk Assessment |
   4.39 Knowledgebase Ancestry Group |
   4.40 Medication Assessed reference to a FHIR resource |
   4.41 Recommended Action |
   4.42 Repeat Motif Order |
   4.43 Therapy Assessed reference to a FHIR resource |
   4.44 Coded Annotation Types |
   4.45 Condition Inheritance Patterns |
   4.46 DNA Change Type |
   4.47 Evidence Level Examples |
   4.48 Functional Effect Value Set |
   4.49 Genetic Therapeutic Implications |
   4.50 HUGO Gene Nomenclature Committee Gene Names (HGNC) |
   4.51 Human Genome Variation Society (HGVS) Nomenclature |
   4.52 Knowledge Base Version Codes |
   4.53 Molecular Biomarker Categories |
   4.54 Molecular Biomarker Codes |
   4.55 Molecular Consequence Value Set |
   4.56 Sequence Phase Relationships |
   4.57 To Be Determined Value Set |
   4.58 Variant Confidence Status |
   4.59 ClinVar Evidence Level Example Codes |
   4.60 Coded Annotation Type Codes |
   4.61 Knowledge Base Codes |
   4.62 Molecular Biomarker Ontology Codes |
   4.63 PharmGKB Evidence Level Example Codes |
   4.64 Sequence Phase Relationship Codes |
   4.65 To Be Determined Codes |
   4.66 Variant Confidence Status Codes |
   4.67 DNA Change Type Map |
   4.68 AnnotationExample |
   4.69 ATR-insertion-molc |
   4.70 ATR-insertion-significance |
   4.71 ATR-insertion-var |
   4.72 bundle-CG-IG-HLA-FullBundle-01 |
   4.73 bundle-cgexample |
   4.74 bundle-cgexample-withGrouping |
   4.75 bundle-complexVariant-nonHGVS |
   4.76 bundle-compound-heterozygote |
   4.77 bundle-CYP2C19 |
   4.78 bundle-oncology-diagnostic |
   4.79 bundle-oncology-report-example |
   4.80 bundle-oncologyexamples-r4 |
   4.81 bundle-oncologyexamples-r4-withGrouping |
   4.82 bundle-pgxexample |
   4.83 bundle-sequence-phase-relation-CYP2C19 |
   4.84 CGPatientExample01 |
   4.85 CNVAnalysis-called |
   4.86 denovoChild |
   4.87 denovoFather |
   4.88 denovoMother |
   4.89 diagnosticImplication-interact-smn1-smn2 |
   4.90 diagnosticreport-hla-glstring-r4 |
   4.91 EGFR-L858R-molc |
   4.92 EGFR-L858R-significance |
   4.93 EGFR-L858R-therapuDrug1 |
   4.94 EGFR-L858R-therapuDrug2 |
   4.95 EGFR-L858R-var |
   4.96 eMERGEServiceRequest |
   4.97 ExampleGermlineCNV |
   4.98 ExampleGermlineDEL |
   4.99 ExampleGermlineINV |
   4.100 ExampleLab |
   4.101 ExampleOrg |
   4.102 ExamplePatient |
   4.103 ExampleServiceRequest |
   4.104 ExampleSomaticCNV |
   4.105 ExampleSomaticDEL |
   4.106 ExampleSomaticINV |
   4.107 ExampleSpecimen |
   4.108 FindALLPopulationSpecificVariantsOutput |
   4.109 FindANYPopulationSpecificVariantsOutput |
   4.110 FindPopulationDxImplicationsOutput |
   4.111 FindPopulationMolecConseqOutput |
   4.112 FindPopulationSpecificHaplotypesOutput |
   4.113 FindPopulationStructuralIntersectingVariantsOutput |
   4.114 FindPopulationStructuralSubsumingVariantsOutput |
   4.115 FindPopulationTxImplicationsOutput |
   4.116 FindStudyMetadataOutput |
   4.117 FindSubjectDxImplicationsOutput |
   4.118 FindSubjectHaplotypesOutput |
   4.119 FindSubjectMolecConseqOutput |
   4.120 FindSubjectSpecificHaplotypesOutput |
   4.121 FindSubjectSpecificVariantsOutput |
   4.122 FindSubjectStructuralIntersectingVariantsOutput |
   4.123 FindSubjectStructuralSubsumingVariantsOutput |
   4.124 FindSubjectTxImplicationsOutput |
   4.125 FindSubjectVariantsOutput |
   4.126 FullGenome-GRCh38 |
   4.127 genomicFileFatherBAM |
   4.128 genomicFileMotherBAM |
   4.129 genomicFileProbandBAM |
   4.130 genomicFileProbandVCF |
   4.131 genomicPatient |
   4.132 GenomicReportExample01 |
   4.133 genomicServiceRequest |
   4.134 GenomicServiceRequestExample01 |
   4.135 genomicSpecimen |
   4.136 GenomicSpecimenExample01 |
   4.137 GenomicSpecimenExample02 |
   4.138 genomicstudy-trio2 |
   4.139 genomicVCFfile-cnv |
   4.140 genomicVCFfile-simple |
   4.141 Genotype-Clinical-Trial-Example-using-haplotypes |
   4.142 genotype-hla-a-glstring-r4 |
   4.143 GenotypeExample1 |
   4.144 GenotypeExamplePharmVar |
   4.145 GenRiskDiabetesT2 |
   4.146 GrouperEx01 |
   4.147 GrouperEx02 |
   4.148 GrouperEx03 |
   4.149 haplotype-hla-a-1-r4 |
   4.150 HaplotypeExamplePharmVar01 |
   4.151 HaplotypeExamplePharmVar02 |
   4.152 HaplotypeSet-Clinical-Trial-Example-1of2 |
   4.153 HaplotypeSet-Clinical-Trial-Example-2of2 |
   4.154 HER2byImmuneStainExample |
   4.155 HER2byImmunoassayExample |
   4.156 HG00403 |
   4.157 HLA-A-haplotype1 |
   4.158 HLA-A-haplotype2 |
   4.159 HLA-B-haplotype1 |
   4.160 HLA-B-haplotype2 |
   4.161 HLA-C-haplotype1 |
   4.162 HLA-C-haplotype2 |
   4.163 ISCN-CMLExample |
   4.164 ISCN-CMLImplication |
   4.165 ISCN-NormalExample |
   4.166 lungMass |
   4.167 MedicationRecommendationExample1 |
   4.168 MedicationStatementWarfarin |
   4.169 MicrosatelliteInstabilityExample01 |
   4.170 molec-conseq1 |
   4.171 molec-conseq2 |
   4.172 molec-conseq3 |
   4.173 molec-conseq4 |
   4.174 MSH2-del-disease |
   4.175 MSH2-del-molc |
   4.176 MSH2-del-var |
   4.177 MSIExample |
   4.178 MultipleRepeatExpansions |
   4.179 normalSpecimen |
   4.180 NOTCH1-significance |
   4.181 NOTCH1-uncertain-molc |
   4.182 NOTCH1-uncertain-var |
   4.183 NTHL1-snv-disease |
   4.184 NTHL1-snv-molc |
   4.185 NTHL1-snv-var |
   4.186 obs-idh-ex |
   4.187 obs1-interact-smn1-smn2 |
   4.188 obs2-interact-smn1-smn2 |
   4.189 orderingPractitioner |
   4.190 pathologistPractitioner |
   4.191 PDL1Example |
   4.192 performingOrganization |
   4.193 Pgx-geno-1001 |
   4.194 Pgx-geno-1002 |
   4.195 Pgx-geno-1003 |
   4.196 Pgx-var-1011 |
   4.197 Pgx-var-1012 |
   4.198 Pgx-var-1013 |
   4.199 Pgx-var-1014 |
   4.200 Pgx-var-1015 |
   4.201 Pgx-var-1016 |
   4.202 Pgx-var-1017 |
   4.203 Pgx-var-1018 |
   4.204 Pgx-var-1019 |
   4.205 Pgx-var-1020 |
   4.206 Pgx-var-1021 |
   4.207 PGxGenomicReportEMERGE |
   4.208 PGxGenomicReportEMERGE-withGrouping |
   4.209 PGXGenomicStudy |
   4.210 PGxRecEx01 |
   4.211 PGxRecEx02 |
   4.212 PGxRecEx03 |
   4.213 PGxRecEx04 |
   4.214 PGxRecEx05 |
   4.215 PolyGenicDiagnosticImpExample |
   4.216 pop-allele-freq |
   4.217 practitioner02 |
   4.218 RepeatExpansion |
   4.219 ROS1-Fusion |
   4.220 ROS1-Fusion-disease |
   4.221 ROS1-Fusion-therapuDrug |
   4.222 ROS1-Fusion-therapuTrial |
   4.223 ROS1-Fusion-var |
   4.224 SequencePhaseRelationExample1 |
   4.225 SequencingProcedure |
   4.226 servicerequest-hla-a-r4 |
   4.227 SimpleVariantAnalysis-called |
   4.228 SNVexample |
   4.229 somaticPatient |
   4.230 somaticReport |
   4.231 somaticServiceRequest |
   4.232 somaticStudy |
   4.233 somaticVCFfile |
   4.234 specimen-hla-r4 |
   4.235 STAG2-insertion-molc |
   4.236 STAG2-insertion-significance |
   4.237 STAG2-insertion-var |
   4.238 supervisorPractitioner |
   4.239 Therapeutic-Implication-Clinical-Trial-2 |
   4.240 Therapeutic-Implication-Clinical-Trial-Somatic |
   4.241 TherapeuticImplicationExample1 |
   4.242 therapuDrug1-interact-smn1-smn2 |
   4.243 therapuDrug2-interact-smn1-smn2 |
   4.244 therapuDrug3-interact-smn1-smn2 |
   4.245 TMB-therapuDrug |
   4.246 TMBExample |
   4.247 triodenovo-software |
   4.248 TumorMutationBurdenExample01 |
   4.249 tumorSpecimen |
   4.250 TxImp01 |
   4.251 TxImp02 |
   4.252 TxImp03 |
   4.253 TxImp04 |
   4.254 TxImp05 |
   4.255 TxImp06 |
   4.256 UncallableRegions |
   4.257 Variant-Somatic-Clinical-Trial |
   4.258 variant-with-molec-consequences |
   4.259 VariantExample |
   4.260 VariantExample1 |
   4.261 VariantExample2 |
   4.262 WES-FullSequencedRegion-GRCh38 |
   4.263 WES-UncallableRegions-GRCh38 |
   4.264 ZFHX3-significance |
   4.265 ZFHX3-uncertain-molc |
   4.266 ZFHX3-uncertain-var |
  5 Variant Reporting |
  6 Cytogenomic Reporting |
  7 Pharmacogenomic Reporting |
  8 Somatic Reporting |
  9 Histocompatibility and Immunogenetic Reporting |
  10 Genomic Operations |
  11 Useful Downloads |
  12 Appendix A: Relation to v2 reporting |
  13 Appendix B: Clinical Genomic Apps |
  14 Appendix C: HL7 Domain Analysis Model |
  15 Appendix D: Query Guidance |
  16 Appendix E: External Coding Systems |
  17 Appendix F: Conversion from FHIR Core STU3 |
  18 Appendix G: Molecular Sequence |
  19 Appendix H: Grouping Guidance |
  20 Appendix I: Glossary |
  21 Change Log |